Latest Observability News

DeSoto Resources has expanded its gold-in-soil anomaly at the Dadjan Gold Project to 3.6km and reported promising high-grade gold zones at Timbakouna, reinforcing the prospectivity of its extensive landholdings in Guinea’s Siguiri Basin.

Gumtree Australia Markets and NZME have signed an MOU to explore launching a new digital automotive marketplace in New Zealand, aiming to challenge the current market leader and tap into a $125 million annual revenue opportunity.

Torque Metals has won a $144,500 co-funded drilling grant from the Western Australian government to explore down-plunge extensions of high-grade gold at its Paris Gold Project, potentially expanding its resource base.

Cygnus Metals reports standout gold and copper drill intercepts at its Golden Eye prospect, signaling a promising new resource within the Chibougamau Copper-Gold Project. The company plans to leverage these results alongside historic data to define an initial Mineral Resource Estimate.

Tivan Limited has responded to ASX inquiries about a social media post by its executive chair concerning fluorite exploration, affirming compliance with disclosure rules and pending assay results.

Alterity Therapeutics is set to present compelling Phase 2 clinical trial results for ATH434 at the 2025 International Multiple System Atrophy Congress, highlighting slowed disease progression and biomarker engagement in MSA patients.

Prospech Limited reports promising metallurgical test results from its Korsnäs Rare Earth Element resource, highlighting apatite as the dominant and well-liberated mineral. The company is fast-tracking bench-scale concentrate production and hydrometallurgical extraction to advance resource development.

Almonty Industries has secured a binding offtake agreement to supply tungsten oxide exclusively for U.S. defense applications, guaranteeing steady demand and pricing for the next three years.

Medallion Metals has reported significant extensional drilling results at its Gem deposit, pushing high-grade gold-copper-silver mineralisation up to 80 metres beyond current resource boundaries and reinforcing plans for near-term sulphide development.

CLINUVEL Pharmaceuticals has completed recruitment for its Phase III trial of SCENESSE® in vitiligo patients with darker skin types, setting the stage for first results in late 2026. Early clinical observations suggest promising repigmentation outcomes.

A landmark High Court ruling in South Africa exempts upstream petroleum activities from the Gas Act, easing regulatory burdens for companies like Renergen and Tetra4.

AUB Group Limited has upgraded its FY25 underlying net profit guidance to the upper end of its previously announced range, buoyed by favourable trading conditions and strategic FX hedging.